
    
      Inclusion Criteria

        -  Males over 18 with documented advanced or metastatic prostate cancer

      Outcome measures

        -  Comparative castration rates one week after starting therapy

        -  Degree of testosterone surge in the first month of treatment.

        -  Maintenance of medical castration during one year of therapy.

        -  Comparison of the treatments on QTc prolongation
    
  